AbbVie (ABBV) Goodwill (2012 - 2026)
AbbVie's (ABBV) quarterly Goodwill came in at $35.5 billion in Q2 2026, little changed year-over-year from $35.6 billion in Q2 2025, and little changed quarter-over-quarter from $35.6 billion in Q1 2026.
Analysis
AbbVie (ABBV) Goodwill (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Goodwill for 15 consecutive years, with $35.5 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Goodwill changed 0.33% year-over-year to $35.5 billion in Q2 2026; TTM through Jun 2026 was $35.5 billion, a 0.33% change from a year earlier, with the FY2025 full-year figure at $35.6 billion, up 1.96% from the prior year.
- Goodwill was $35.5 billion for Q2 2026 at AbbVie, roughly flat from $35.6 billion in the prior quarter.
- Over five years, Goodwill peaked at $35.6 billion in Q4 2025 and troughed at $31.7 billion in Q3 2022.
- A 5-year average of $33.7 billion and a median of $33.4 billion in 2024 frame the typical range for Goodwill.
- Across the five-year window, Goodwill decreased 1.76% in 2022 and climbed 9.98% in 2024, its largest moves.
- Over 5 years, Goodwill stood at $32.2 billion in 2022, then advanced by 0.43% to $32.3 billion in 2023, then grew by 8.25% to $35.0 billion in 2024, then grew by 1.96% to $35.6 billion in 2025, then declined by 0.34% to $35.5 billion in 2026.
- The last three Goodwill figures came in at $35.5 billion (Q2 2026), $35.6 billion (Q1 2026), and $35.6 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
| 10 | Jazz Pharmaceuticals | 16.02 Bn | 14.40 Bn | 1.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.52 Bn |
| Mar 31, 2026 | 35.57 Bn |
| Dec 31, 2025 | 35.64 Bn |
| Sep 30, 2025 | 35.63 Bn |
| Jun 30, 2025 | 35.64 Bn |
| Mar 31, 2025 | 35.29 Bn |
| Dec 31, 2024 | 34.96 Bn |
| Sep 30, 2024 | 35.30 Bn |
| Jun 30, 2024 | 33.39 Bn |
| Mar 31, 2024 | 33.43 Bn |
| Dec 31, 2023 | 32.29 Bn |
| Sep 30, 2023 | 32.09 Bn |
| Jun 30, 2023 | 32.22 Bn |
| Mar 31, 2023 | 32.22 Bn |
| Dec 31, 2022 | 32.16 Bn |
| Sep 30, 2022 | 31.73 Bn |
| Jun 30, 2022 | 32.03 Bn |
| Mar 31, 2022 | 32.30 Bn |
| Dec 31, 2021 | 32.38 Bn |
| Sep 30, 2021 | 32.30 Bn |